Evaluation of Fat Accumulation and Adipokine Production during the Long-Term Adipogenic Differentiation of Porcine Intramuscular Preadipocytes and Study of the Influence of Immunobiotics.
Adipocytes
/ cytology
Adipogenesis
Adiponectin
/ biosynthesis
Adiposity
Animals
Cell Count
Cell Line
Cell Proliferation
Cell Size
Fatty Acids
/ biosynthesis
Inflammation
/ pathology
Leptin
/ biosynthesis
Ligands
Muscles
/ cytology
Swine
Toll-Like Receptors
/ metabolism
Tumor Necrosis Factor-alpha
/ metabolism
adipokines
fat accumulation
immunobiotics
inflammation
long-term adipogenic differentiation (LTAD)
porcine intramuscular adipocyte
Journal
Cells
ISSN: 2073-4409
Titre abrégé: Cells
Pays: Switzerland
ID NLM: 101600052
Informations de publication
Date de publication:
17 07 2020
17 07 2020
Historique:
received:
19
02
2020
revised:
13
07
2020
accepted:
15
07
2020
entrez:
26
7
2020
pubmed:
28
7
2020
medline:
5
3
2021
Statut:
epublish
Résumé
The degree of fat accumulation and adipokine production are two major indicators of obesity that are correlated with increased adipose tissue mass and chronic inflammatory responses. Adipocytes have been considered effector cells for the inflammatory responses due to their capacity to express Toll-like receptors (TLRs). In this study, we evaluated the degree of fat accumulation and adipokine production in porcine intramuscular preadipocyte (PIP) cells maintained for in vitro differentiation over a long period without or with stimulation of either TNF-α or TLR2-, TLR3-, or TLR4-ligands. The cytosolic fat accumulation was measured by liquid chromatography and the expression of adipokines (CCL2, IL-6, IL-8 and IL-10) were quantified by RT-qPCR and ELISA at several time points (0 to 20 days) of PIP cells differentiation. Long-term adipogenic differentiation (LTAD) induced a progressive fat accumulation in the adipocytes over time. Activation of TLR3 and TLR4 resulted in an increased rate of fat accumulation into the adipocytes over the LTAD. The production of CCL2, IL-8 and IL-6 were significantly increased in unstimulated adipocytes during the LTAD, while IL-10 expression remained stable over the studied period. An increasing trend of adiponectin and leptin production was also observed during the LTAD. On the other hand, the stimulation of adipocytes with TLRs agonists or TNF-α resulted in an increasing trend of CCL2, IL-6 and IL-8 production while IL-10 remained stable in all four treatments during the LTAD. We also examined the influences of several immunoregulatory probiotic strains (immunobiotics) on the modulation of the fat accumulation and adipokine production using supernatants of immunobiotic-treated intestinal immune cells and the LTAD of PIP cells. Immunobiotics have shown a strain-specific ability to modulate the fat accumulation and adipokine production, and differentiation of adipocytes. Here, we expanded the utility and potential application of our in vitro PIP cells model by evaluating an LTAD period (20 days) in order to elucidate further insights of chronic inflammatory pathobiology of adipocytes associated with obesity as well as to explore the prospects of immunomodulatory intervention for obesity such as immunobiotics.
Identifiants
pubmed: 32708964
pii: cells9071715
doi: 10.3390/cells9071715
pmc: PMC7408200
pii:
doi:
Substances chimiques
Adiponectin
0
Fatty Acids
0
Leptin
0
Ligands
0
Toll-Like Receptors
0
Tumor Necrosis Factor-alpha
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Références
Atherosclerosis. 2016 Jan;244:211-5
pubmed: 26687466
Methods Enzymol. 2014;537:93-122
pubmed: 24480343
Nat Rev Mol Cell Biol. 2019 Apr;20(4):242-258
pubmed: 30610207
Comp Biochem Physiol B Biochem Mol Biol. 2008 Feb;149(2):285-92
pubmed: 17977041
Obesity (Silver Spring). 2009 Apr;17(4):648-56
pubmed: 19148127
J Biol Chem. 2001 May 18;276(20):16683-9
pubmed: 11278967
Biochim Biophys Acta. 2008 Feb;1782(2):99-108
pubmed: 18179777
Adipocyte. 2015 Jan 07;4(2):149-52
pubmed: 26167419
Diabetes Care. 2008 Sep;31(9):1827-31
pubmed: 18556339
Adipocyte. 2014 Dec 10;3(4):242-55
pubmed: 26317048
J Nutr Biochem. 2012 Feb;23(2):113-22
pubmed: 21414767
Gastroenterology. 2007 May;132(6):2169-80
pubmed: 17498510
Gene Ther. 2017 Jan;24(1):60-66
pubmed: 27858942
Obesity (Silver Spring). 2008 May;16(5):932-7
pubmed: 18292749
J Appl Behav Anal. 2014 Fall;47(3):485-99
pubmed: 24842700
PLoS One. 2013;8(1):e53626
pubmed: 23341960
Biomed Res Int. 2015;2015:673651
pubmed: 26090433
Obesity (Silver Spring). 2015 Mar;23(3):512-8
pubmed: 25612251
J Clin Endocrinol Metab. 2011 Dec;96(12):E2045-9
pubmed: 21994963
J Clin Endocrinol Metab. 2007 Mar;92(3):1023-33
pubmed: 17164304
Cell Transplant. 2020 Jan-Dec;29:963689720917341
pubmed: 32314614
PLoS One. 2015 Mar 19;10(3):e0119644
pubmed: 25789857
Eur J Pharmacol. 2016 Aug 15;785:24-35
pubmed: 27085899
Trends Endocrinol Metab. 2012 Aug;23(8):391-8
pubmed: 22721584
Nat Rev Endocrinol. 2017 Nov;13(11):633-643
pubmed: 28799554
Arch Physiol Biochem. 2011 Jul;117(3):151-64
pubmed: 21599616
Adipocyte. 2012 Jul 1;1(3):153-156
pubmed: 23700524
Am J Physiol Endocrinol Metab. 2009 Nov;297(5):E987-98
pubmed: 19738037
J Cell Physiol. 2018 Jan;233(1):88-97
pubmed: 28181253
Diabetologia. 2015 Nov;58(11):2627-36
pubmed: 26245186
Cell Metab. 2014 Jul 1;20(1):103-18
pubmed: 24930973
PLoS One. 2015 Apr 13;10(4):e0123152
pubmed: 25867514
Biogerontology. 2018 Dec;19(6):447-459
pubmed: 30054761
Clin Sci (Lond). 2016 Sep 1;130(18):1603-14
pubmed: 27503945
Proc Nutr Soc. 2010 May;69(2):232-43
pubmed: 20158940
Int J Mol Sci. 2019 May 13;20(9):
pubmed: 31085992
FEBS Lett. 2008 Jan 9;582(1):117-31
pubmed: 18037376
J Biol Chem. 1957 May;226(1):497-509
pubmed: 13428781
Diabetes. 2005 Dec;54(12):3503-9
pubmed: 16306368
Stem Cells. 2012 May;30(5):965-74
pubmed: 22367678
Cells. 2020 Apr 02;9(4):
pubmed: 32252348
Front Immunol. 2019 May 29;10:1180
pubmed: 31191544
Front Immunol. 2017 Nov 17;8:1580
pubmed: 29250061
BMC Microbiol. 2014 May 16;14:126
pubmed: 24886142
Trends Immunol. 2007 Sep;28(9):393-9
pubmed: 17681884
FEMS Immunol Med Microbiol. 2003 Aug 18;38(1):9-12
pubmed: 12900049
Adipocyte. 2013 Oct 1;2(4):217-26
pubmed: 24052897
Mol Cell Endocrinol. 2001 Apr 25;175(1-2):81-92
pubmed: 11325518
Gut. 2009 Apr;58(4):586-93
pubmed: 19017686
Cardiovasc Res. 2010 Jan 1;85(1):17-27
pubmed: 19643806
Microbiol Immunol. 2012 Dec;56(12):847-54
pubmed: 23017059
Microbiol Immunol. 2009 Aug;53(8):475-80
pubmed: 19659932
Nat Rev Immunol. 2010 Dec;10(12):826-37
pubmed: 21088683
Ann Med. 2015 Mar;47(2):150-68
pubmed: 24915455
Sci Rep. 2017 Jun 7;7(1):3000
pubmed: 28592801
Front Immunol. 2017 Mar 13;8:266
pubmed: 28348560
J Clin Invest. 2006 Jun;116(6):1494-505
pubmed: 16691291
J Med Invest. 2017;64(3.4):193-196
pubmed: 28954980
Int J Mol Sci. 2020 Jan 18;21(2):
pubmed: 31963662
Scand J Immunol. 2012 Oct;76(4):359-70
pubmed: 22690903
Infect Immun. 2007 Mar;75(3):1066-78
pubmed: 17118983